UOG Journal Club: August 2017

Slides:



Advertisements
Similar presentations
UOG Journal Club: November 2011 Ultrasound prediction of miscarriage
Advertisements

 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Dr. Y. Shah MD, Associate Dean of Global Health, DMU Lindsay Zylstra, Central College.
Epidemiology of high birth weight (HBW) José M. Olmas, MD; Professor of Obstetrics and Master in Maternal-Child Health And Eduardo Halac, MD; Professor.
Congenital malformations and birth weight: a family perspective Dr. Kari K.Melve Department of Public Health & Primary Health Care University of Bergen,
UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
بسم الله الرّحمن الرّحیم Hypertension in pregnancy R.Mohammadjafari.MD.Gynecologist.
Small Babies IUGR and SGA. Small-for-gestational-age A baby whose birth weight or estimated fetal weight is below a specified centile for its gestation.
Growth Assessment Protocol
Notes  Data are presented as a pair of overlying bars, the outer, wider bar representing the period 1st Oct 2007 to 30th September 2008, and the inner,
POSTTERM PREGNANCY AZZA ALYAMANI OBSTETRICS & GYNICOLOGY Department
UOG Journal Club: August 2011
Max Brinsmead MB BS PhD May Definition and Incidence  Prolonged pregnancy is defined as that proceeding beyond 42 weeks gestation  In the absence.
UOG Journal Club: July 2013 Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis G. Pagani, F. D’Antonio,
POSTTERM PREGNANCY: THE IMPACT ON MATERNAL AND FETAL OUTCOME Dr. Hussein. S. Qublan- Al-Hammad Jordanian Board in Obstet &Gynecology European Board in.
Definition & Risk Factors of FGR FGR, also called IUGR is the term used to describe a fetus that has not reached its growth potential because of genetic.
Mei-Chun LU, Song-Shan HUANG, Yuan-Horng YAN, Panchalli WANG, Yueh-Han HSU, Wei CHEN Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi,
UOG Journal Club: January 2016 Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results.
Middle cerebral artery peak systolic velocity: a new Doppler parameter in the assessment of growth-restricted fetus G.MARI, F HANIF, M KRUGER, et. al,.
UOG Journal Club: March 2016 Prediction of large-for-gestational-age neonates: screening by maternal factors and biomarkers in the three trimesters of.
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
UOG Journal Club: June 2016 Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial):
UOG Journal Club: February 2016
UOG Journal Club: June 2017 Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE.
UOG Journal Club: March 2017
UOG Journal Club: January 2017
M. Boyle1,3,4, R. Pinnamaneni 2,3,4, F. Malone 2,4, J
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder,
UOG Journal Club: January 2016
UOG Journal Club: March 2016
In term, uncomplicated pregnancies, can intrapartum
UOG Journal Club: June 2016 Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial):
Inonu University, Turgut Ozal Medical Centre
UOG Journal Club: October 2016
Child Health Lec- 4 Prof Dr Najlaa Fawzi.
UOG Journal Club: May 2017 Increased nuchal translucency thickness and risk of neurodevelopmental disorders S.G. Hellmuth, L.H. Pedersen, C.B. Miltoft,
UOG Journal Club: May 2017 Increased nuchal translucency thickness and risk of neurodevelopmental disorders S.G. Hellmuth, L.H. Pedersen, C.B. Miltoft,
Keerti Singh, C Greaves, L Mohammed, A Kumar.
Journal Club Notes.
UOG Journal Club: March 2017
Department of Obstetrics & Gynecology
Introduction Materials and Methods Results Conclusions
UOG Journal Club: January 2018
UOG Journal Club: December 2017
UOG Journal Club: March 2018
Gestational Diabetes Lab 4.
UOG Journal Club: September 2018
Pediatric consequences of Assisted Reproductive Technologies
UOG Journal Club: April 2017
UOG Journal Club: December 2016
UOG Journal Club: July 2012 Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia A. Khalil, R. Akolekar, A. Syngelaki, M. Elkhouli.
UOG Journal Club: November 2016
Fetal Medicine Foundation fetal and neonatal population weight charts
UOG Journal Club: August 2018
Perinatal Epidemiology
Measuring Health Status
UOG Journal Club: October 2018
Figure cases 24 cases: neonatal or infant death
Finn Lauszus, Hanne Søndergaard, Carsten Byrialsen, Ervin Kallfa
UOG Journal Club: December 2018
Dr. Elahe Zarean Dr. Sharzad Shabaninia
UOG Journal Club: February 2019 systematic review and meta-analysis
Blastocyst versus cleaved embryo transfer: do we have enough evidence?
Customized Charts and Their Role in Identifying Pregnancies at Risk Because of Fetal Growth Restriction  Jason Gardosi, MD, FRCOG  Journal of Obstetrics.
UOG Journal Club: May 2019 Premature placental aging in term small-for-gestational-age and growth-restricted fetuses C. PAULES, A.P. DANTAS, J. MIRANDA,
UOG Journal Club: September 2019
Chantal Nelson BORN Annual Conference April 25, 2017
UOG Journal Club: October 2019
Presentation transcript:

UOG Journal Club: August 2017 Customized vs population-based growth charts to identify neonates at risk of adverse outcome: systematic review and Bayesian meta-analysis of observational studies G. Chiossi, C. Pedroza, M. M. Costantine, V. T. T. Truong, G. Gargano and G. R. Saade Volume 50, Issue 2, Date: August (pages 156–166) Journal Club slides prepared by Dr Yael Raz (UOG Editor for Trainees)

Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Introduction Birth weight is determined by a combination of genetic, intrauterine and environmental influences. Infants born SGA (birth weight <10th centile) or LGA (birth weight >90th centile) are at increased risk of adverse health outcomes. Population-based norms do not differentiate between abnormal growth and constitutionally large or small, but otherwise healthy, fetuses. Relying on these norms may lead to misclassification of birth weight and over- or underdiagnosis of fetal growth abnormalities.

Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Introduction Customized norms model optimal fetal growth by accounting for individual variables that are known to affect growth Customized norms allow assessment of deviations from a presumed ideal fetal growth potential, rather than deviations from a poppulation-based norm. Early studies suggested that customized norms can better identify neonates at risk BUT more recent reports do not support this conclusion.

Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Aim of the study To determine which classification (customized or population-based growth charts) has the strongest association with adverse outcomes when birth weight is outside the norm.

Methods Studies were included if they Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Methods Studies were included if they compared adverse neonatal outcomes compared adverse maternal outcomes Assessed both SGA or LGA neonates Used both customized and population-based norms A random-effects Bayesian meta-analysis was performed to compute pooled odds ratios (ORs) of adverse outcomes among SGA and LGA pregnancies, classified according to population-based or customized norms, when compared with non-SGA and non-LGA neonates

Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Results

Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Results Customized centiles were obtained according to the approach described by Gardosi et al. which takes into account maternal height, weight, parity, ethnic origin and gestational age at delivery. One study referred to the more complex model by Bukowski et al. that also takes into consideration prior pregnancies, marital status, maternal education and first- and second-trimester screening results. Population-based centiles were derived from sex-adjusted standards specific for the population enrolled in each study.

Intrauterine Fetal Death in SGA neonates Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Results Intrauterine Fetal Death in SGA neonates Population-based Customized

Neonatal Death in SGA neonates Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Results Neonatal Death in SGA neonates Population-based Customized

Perinatal Death in SGA neonates Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Results Perinatal Death in SGA neonates Population-based Customized

NICU admission in SGA neonates Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Results NICU admission in SGA neonates Population-based Customized

Shoulder dystocia in LGA neonates Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Results Shoulder dystocia in LGA neonates Population-based Customized LGA pregnancies had a similar risk of perinatal death, NICU admission, maternal third- and fourth-degree perineal lacerations and neonatal hypoglycemia when compared with non-LGA pregnancies – by population or customized norms

Discussion SGA neonates: Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Discussion SGA neonates: Appear to be at greater risk for IUFD, neonatal death, perinatal death and NICU admission than do non-SGA neonates, using either customized or population-based growth charts. A customized approach led to higher ORs for the studied outcomes, suggesting that it may better identify patients at risk. However, the strength of any conclusions regarding the superiority of this method is hindered by the overlapping CIs.

Discussion LGA neonates: Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Discussion LGA neonates: Did not appear to be at increased risk for perinatal death, NICU admission, maternal 3rd/4th-degree perineal lacerations or neonatal hypoglycemia, using either customized or population-based growth charts. Both approaches indicated an increased risk for shoulder dystocia These findings may be because of the limited number of studies addressing these outcomes. It may be that absolute weight is more important in determining outcome in these large fetuses compared with an individualized approach.

Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Discussion IUGR constitutes the largest single at-risk category among normally formed fetuses experiencing in-utero demise and is also associated with increased risks of perinatal mortality, morbidity and long-term adverse health outcomes. Most cases of IUGR are due to late-onset (term) placental insufficiency. The majority of deaths associated with fetal-growth problems are potentially avoidable through better assessment and surveillance. This meta-analysis does not conclude that customized norms can better define a population of pathologically small fetuses that are at higher risk of adverse perinatal outcomes, although a recent prospective observational study suggested such a conclusion.

Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Limitations No randomized controlled studies addressed the research question and therefor only observational studies are included. Studies differed in their definitions of various outcomes: IUFD – after 20 weeks’ gestation / after 22 weeks’ gestation NICU admission – stay of >48h / stay of >7 days. Patient-level data not available - impossible to determine if the ORs for each outcome were significantly different when fetuses were classified by customized vs population-based norms.

Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Conclusions Both customized and population-based growth charts can detect intrauterine growth disturbances that are associated with adverse perinatal outcomes, particularly for SGA neonates. Although point estimates of pooled ORs may differ for some of these outcomes, their overlapping CIs prevents any firm conclusions about the superiority of one method or the other.

Customized vs population-based growth charts to identify neonates at risk of adverse outcome G Chiossi et al. UOG 2017 Points for discussion Should customized growth charts be used assessing SGA, LGA or for all cases? Why does customization not improve detection of adverse outcome? Is birth weight customization for a factor related to adverse outcome (such as obesity and racial origin) biologically justified? Are prescriptive (prospective) population-based charts such as those from INTERGROWTH-21st any more likely to predict adverse outcome? Is lack of nutrition (poor growth) or lack of oxygen (lack of respiration) more likely to result in fetal demise and adverse neonatal outcome? Is deviation of fetal growth from the ideal/optimum always an accurate proxy for failure of placental oxygen transfer?